Malaria
Overview
Malaria is a life-threatening blood disease caused by a
parasite (Plasmodium) that is transmitted to humans by the Anopheles mosquito.
People at increased risk of serious disease include young children and infants,
travelers coming from areas with no malaria and pregnant women and their unborn
children. Symptoms may include fever, chills, headache, sweats, fatigue,
enlarged spleen, nausea and vomiting. Treatment includes anti-malarial
medicines and healthy lifestyle.
Click here for sample
report @ http://www.wiseguyreports.com/sample-request/1306988-malaria-pipeline-review-h1-2017
Malaria Industry Major Outlook
The Pharmaceutical and Healthcare latest pipeline guide
Malaria - Pipeline Review, H1 2017, provides comprehensive information on the
therapeutics under development for Malaria (Infectious Disease), complete with
analysis by stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type. The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases.
The Malaria (Infectious Disease) pipeline guide also reviews
of key players involved in therapeutic development for Malaria and features
dormant and discontinued projects. The guide covers therapeutics under
Development by Companies /Universities /Institutes, the molecules developed by
Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are
2, 12, 10, 55 and 31 respectively. Similarly, the Universities portfolio in
Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 3,
11, 45 and 41 molecules, respectively.
Malaria (Infectious Disease) pipeline guide helps in
identifying and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective counter
strategies to gain competitive advantage. Additionally, various dynamic
tracking processes ensure that the most recent developments are captured on a
real time basis.
Malaria - Competitive Analysis
Key players are making innovative developments in Malaria industry. The same will help in improving the market
performance. Heavy investments are made by major players in the R&D sector
Scope
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Malaria (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Malaria (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Malaria (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Malaria (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Malaria (Infectious Disease)
- The pipeline guide reviews pipeline therapeutics for Malaria (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Malaria (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Malaria (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Malaria (Infectious Disease)
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1306988-malaria-pipeline-review-h1-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt.
Ltd. and offers premium progressive statistical surveying, market research
reports, analysis & forecast data for industries and governments around the
globe. Wise Guy Reports understand how essential statistical surveying
information is for your organization or association. Therefore, we have
associated with the top publishers and research firms all specialized in
specific domains, ensuring you will receive the most reliable and up to date
research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment